MIRA Pharmaceuticals
MIRA
20 hedge funds and large institutions have $1.21M invested in MIRA Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
28% more capital invested
Capital invested by funds: $949K → $1.21M (+$261K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 19 → 20 (+1)
0.06% more ownership
Funds ownership: 5.85% → 5.91% (+0.06%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$40.4K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$26.1K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$25.3K |
| 4 |
Mariner
Overland Park,
Kansas
|
+$5.77K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$4.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWM
Praetorian Wealth Management
Carmel,
California
|
-$17.1K |
| 2 |
Jane Street
New York
|
-$14.5K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$11.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10.8K |
| 5 |
CSI
Cross Staff Investments
Pittsford,
New York
|
-$4.62K |
MIRA Hedge Fund Activity: Q2 2025 in Review
20 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q2 2025, worth a combined $1.21M — up 28% from $949K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MIRA positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was International Assets Investment Management, opening a new position worth an estimated $40.4K. The largest seller was Praetorian Wealth Management, exiting entirely with an estimated $17.1K sold.
- 20 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q2 2025, up from 19 in Q1 2025.
- Funds reported $1.21M of MIRA Pharmaceuticals stock for Q2 2025, up 28% quarter-over-quarter.
- 5 funds opened new MIRA Pharmaceuticals positions in Q2 2025 and 4 closed out, a net change of +1 holder.
- The largest MIRA Pharmaceuticals buyer in Q2 2025 was International Assets Investment Management, an estimated $40.4K added.
- The largest MIRA Pharmaceuticals seller in Q2 2025 was Praetorian Wealth Management, an estimated $17.1K sold.
Based on aggregated 13F filings for Q2 2025.